Docetaxel and Gemcitabine in the Treatment of Soft Tissue Sarcoma – A Single-Center Experience

Peter R. Ebeling,Lewin Eisele,P Schuett,Sebastian Bauer,Jochen Schuette,Thomas Moritz,S. Seeber,Michael Flasshove

Docetaxel and Gemcitabine in the Treatment of Soft Tissue Sarcoma – A Single-Center Experience

2008

Peter R. Ebeling
Lewin Eisele
P Schuett
Sebastian Bauer
Jochen Schuette
Thomas Moritz
S. Seeber
Michael Flasshove

Introduction: Advanced stage/metastatic soft tissue sarcoma (STS) has a poor prognosis especially after failure of the established first-line treatment. In patients with relapsed leiomyosarcoma, ho

Keywords:

Pathology
Leiomyosarcoma
Side effect
Single Center
Relapsed Leiomyosarcoma
Gemcitabine
Oncology
Soft tissue sarcoma
Docetaxel
Medicine
Salvage therapy
Internal medicine
in patient
poor prognosis
advanced stage

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations